Validation of risk assessment models for predicting the incidence of breast cancer in Korean women

Journal of Breast Cancer

Volumn 17, Issue 3, 2014, Pages 226-235

  Min, Jun Won ^a   Chang, Myung Chul ^a   Lee, Hae Kyung ^b   Hur, Min Hee ^b   Noh, Dong Young ^c   Yoon, Jung Han ^d   Jung, Yongsik ^e   Yang, Jung Hyun ^f  

^a Dankook University College of Medicine   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Chonnam National University Research Institute of Medical Sciences   (South Korea)

^e Ajou University School of Medicine   (South Korea)

^f Konkuk University School of Medicine   (South Korea)

Author keywords

Breast neoplasms; Risk assessment; Validation studies

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; ASIAN AMERICAN GAIL MODEL; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; COMPARATIVE STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISCRIMINANT ANALYSIS; FEMALE; GAIL MODEL; HUMAN; INCIDENCE; KOREA; KOREAN MODEL; MAJOR CLINICAL STUDY; MIDDLE AGED; MORTALITY; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; RISK ASSESSMENT; RISK FACTOR; RISK SSSESSMENT MODEL; VALIDATION STUDY;

EID: 84926505351     PISSN: 17386756     EISSN: 20929900     Source Type: Journal    
DOI: 10.4048/jbc.2014.17.3.226     Document Type: Article

References (17)

1. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86.
2. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-88.
3. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006;295: 2727-41.
4. Chay WY, Ong WS, Tan PH, Jie Leo NQ, Ho GH, Wong CS, et al. Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women. Breast Cancer Res 2012;14:R19.
5. Kim SH, Chae YS, Son WJ, Shin DJ, Kim YM, Chang MC. Estimation of individualized probabilities of developing breast cancer for Korean women. J Korean Surg Soc 2008;74:405-11.
6. Park SK, Yoo KY, Kang DH, Ahn SH, Noh DY, Choe KJ. The estimation of breast cancer disease-probability by difference of individual susceptibility. Cancer Res Treat 2003;35:35-51.
7. Ko BS, Noh WC, Kang SS, Park BW, Kang EY, Paik NS, et al. Changing patterns in the clinical characteristics of Korean breast cancer from 1996-2010 using an online nationwide breast cancer database. J Breast Cancer 2012;15:393-400.
8. Matsuno RK, Costantino JP, Ziegler RG, Anderson GL, Li H, Pee D, et al. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst 2011; 103:951-61.
9. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993;85:1819-27.
10. Korean Statistical Information System. 2013. Korea National Statistical Office. http://www.kosis.kr/. Accessed November 1st, 2013.
11. Schonfeld SJ, Pee D, Greenlee RT, Hartge P, Lacey JV Jr, Park Y, et al. Effect of changing breast cancer incidence rates on the calibration of the Gail model. J Clin Oncol 2010;28:2411-7.
12. Spiegelman D, Colditz GA, Hunter D, Hertzmark E. Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 1994;86:600-7.
13. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001;93:358-66.
14. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography: a meta-analysis. JAMA 1995;273:149-54.
15. Kim SH, Kim MH, Oh KK. Analysis and comparison of breast density according to age on mammogram between Korean and Western women. J Korean Radiol Soc 2000;42:1009-14.
16. Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, et al. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 1999;91:1829-46.
17. Kim DU, Min JW, Kim YM, Chang MC. Estimating the risks and benefits of tamoxifen for prophylactic breast cancer chemoprevention in Korea. J Breast Cancer 2012;15:51-6.